Most Recent Articles about NVS
Novartis Announces Data on Tafinlar, Mekinist & Piqray at ESMO http://www.zacks.com/stock/news/1061064/novartis-announces-data-on-tafinlar-mekinist-piqray-at-esmo?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1061064 Sep 21, 2020 - Novartis (NVS) announces data from late-stage studies on Tafinlar, Mekinist and Piqray at ESMO 2020.
All You Need to Know About Ahold NV (ADRNY) Rating Upgrade to Buy http://www.zacks.com/stock/news/1060450/all-you-need-to-know-about-ahold-nv-adrny-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-1060450 Sep 18, 2020 - Ahold NV (ADRNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Investors Undervaluing Ahold NV (ADRNY) Right Now? http://www.zacks.com/stock/news/1060408/are-investors-undervaluing-ahold-nv-adrny-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-1060408 Sep 18, 2020 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Related Companies

Name Exchange Price Mkt Cap
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals